Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q2 2019 Earnings

6AugExpected

Q3 2018

Q4 2018

Q1 2019

Q2 2019

-15.5

-10.46

-5.41

-0.37

Details

Expected EPS

-0.48

Actual EPS

-13.75

Surprise EPS

-13.27

Surprise Percent

+2,764.58%

Description

Spyre Therapeutics (SYRE) has reported earnings of -13.75 per share for Q2 2019.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.